CT
CTT Pharmaceutical Holdings, Inc.
CTTH · OTC
$0.05 -0.21% (-$0.00)
1M -9.16%
Market Cap $2.90M
P/E Ratio -
Div. Yield -
ROE 324.21%
Bulios Fair Price
$0.05
3.1% upside
Current Price
$0.049
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CTTH is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 111.45x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 14.82%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 284.29%
Asset turnover 0.00x
ROE 324.21%
Debt
30 /100
High Debt/Equity 0.75x
Int. coverage -48.45x
Current ratio 0.00x
Stability
37 /100
Moderate Beta 0.72x
Profitable years 0
EPS volatility 240.48%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CTTH
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Ryan Khouri
Employees
1
Headquarters
Tampa